The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.

about

Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.

P2860

Q55398868-029DDFAD-2E1C-4A34-92D3-87C78824C5A7 Q55439726-DBAEFB09-2BA5-4395-9B71-C5C90CD104EB

P2860

The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.

Item

http://www.wikidata.org/entity/Q38786934

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The tumor antigen N-glycolyl-G ...... ral killer T cell interaction.

@en

type

Item

label

The tumor antigen N-glycolyl-G ...... ral killer T cell interaction.

@en

prefLabel

The tumor antigen N-glycolyl-G ...... ral killer T cell interaction.

@en

P1476

The tumor antigen N-glycolyl-G ...... ral killer T cell interaction.

@en

P2093

Eloísa Arana

http://www.w3.org/2001/XMLSchema#string

Leonardo Fainboim

http://www.w3.org/2001/XMLSchema#string

M Eugenia Pérez

http://www.w3.org/2001/XMLSchema#string

M Virginia Gentilini

http://www.w3.org/2001/XMLSchema#string

Pablo Mariano Fernández

http://www.w3.org/2001/XMLSchema#string

P2860

Determination of cellular lipids bound to human CD1d molecules.

Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.

Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected]

A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity

NGcGM3 ganglioside: a privileged target for cancer vaccines

The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides.

Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.

Identification of self-lipids presented by CD1c and CD1d proteins.

P2888

s00262-016-1812-y

P304

551-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-016-1812-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052352504

http://www.w3.org/2001/XMLSchema#string

P698

26969612

http://www.w3.org/2001/XMLSchema#string

The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.

about

P2860

P2860

The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698